SCHEMBL6223373

SCHEMBL6223373

O=C(CCC(Nc1ncnc2cc(C(=O)N3CCCC3)c(Cl)cc12)c1nc2ccc(Cl)cc2[nH]1)NCC1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.38
KMT2A Q03164 1/20 0.36
HRH4 Q9H3N8 3/20 0.35
HRH3 Q9Y5N1 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
F10 P00742 1/20 0.34
CNR1 P21554 7/20 0.34
GRIN2B Q13224 1/20 0.34
CTSD P07339 1/20 0.34
KCNH2 Q12809 1/20 0.34
BACE2 Q9Y5Z0 1/20 0.34
CNR2 P34972 3/20 0.34
RIPK1 Q13546 1/20 0.34
EGFR P00533 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3003921 0.95 BACE1 (0.40) BACE1KMT2AHRH4HRH3CNR1
SCHEMBL6224761 0.90 POLB (0.42) KMT2AHRH4HRH3LMNAL3MBTL1
SCHEMBL3000397 0.90 BACE1 (0.34) BACE1KMT2AHRH4CNR1CNR2
SCHEMBL6224252 0.89 POLB (0.39) KMT2AHRH4HRH3LMNAL3MBTL1
SCHEMBL2995737 0.89 BACE1 (0.34) BACE1KMT2ACNR1CNR2EGFR
SCHEMBL6226058 0.87 HRH4 (0.41) HRH4HRH3CNR1CNR2EGFR
SCHEMBL8322256 0.85 TSHR (0.44) KMT2ALMNAL3MBTL1POLB
SCHEMBL3002040 0.85 POLB (0.37) KMT2AHRH4HRH3LMNAL3MBTL1
SCHEMBL2995802 0.84 CNR1 (0.40) HRH4HRH3CNR1CNR2EGFR
SCHEMBL3004953 0.84 KMT2A (0.36) BACE1KMT2AHRH4HRH3CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583757-A1 NOVEL SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES AND USE THEREOF AS FACTOR XA INHIBITORS Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2005-10-12 EP disclosed
WO-2004058743-A1 NOVEL SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES AND USE THEREOF AS FACTOR XA INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-15 WO disclosed